AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "gp019-management-of-recurrent-miscarriages-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 2083
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Recurrent Miscarriage Management Guideline",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "Brighton & Sussex University Hospitals",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "The text does not contain a publication year. If you have the full document or additional context, please provide it so I can assist further",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of Recurrent Miscarriage Guideline (GP019)** **Patient Selection:** Investigate women with ≥3 consecutive first-trimester miscarriages, ≥1 second-trimester miscarriage, ≥2 first-trimester miscarriages if age ≥38, or markers of Antiphospholipid syndrome (APLS). **Investigations:** - **APLS testing:** Blood tests (lupus anticoagulant, anticardiolipin) ≥6 weeks post-loss. - **Cytogenetics:** Offer karyotyping after third consecutive miscarriage. - **Thrombophilia screen:** Only for second-trimester loss; LMWH advised if positive. **Management:** - No abnormality found: Reassure and offer early EPU contact. - Anti-D administration: Follow current miscarriage guidelines. **Responsibilities:** Staff must follow guidance, applying professional judgment. Protocols should be regularly reviewed and accessible",
      "action": "added"
    }
  ]
}